ESWT Shockwave vs P-Shot: Which Is Better for Erectile Dysfunction in Malaysia?

Men’s Health · ED Treatment · Rawang Selangor

Both ESWT and the P-Shot treat erectile dysfunction without surgery or daily medication. But they work differently, target different aspects of ED biology, and suit different patient profiles. This is the honest comparison.

📅 May 2026  |  Vivardi Clinics, Rawang

Men researching treatment options for erectile dysfunction increasingly encounter two non-pharmacological approaches: ESWT shockwave therapy and the P-Shot (PRP injection). Both are legitimate, evidence-backed treatments. Both are non-surgical. But they work through different mechanisms, have different evidence bases, and suit different clinical situations. This guide gives you the honest clinical comparison so you can have an informed conversation with your doctor.

The Root Cause of Most Erectile Dysfunction: Vascular

Before comparing treatments, understanding the most common cause of ED is essential. Approximately 52% of men between 40-70 experience some degree of ED. In the majority of these cases, particularly in men over 40, the primary cause is vascular — specifically, endothelial dysfunction (impaired function of the inner lining of blood vessels).

An erection requires a very specific vascular event: rapid, massive blood flow into the corpora cavernosa (the erectile tissue). This is triggered by nitric oxide (NO) release from endothelial cells, which relaxes smooth muscle in penile arteries and allows blood to flood in. When endothelial function is impaired, NO production is inadequate, smooth muscle does not relax fully, and erection quality declines.

Risk factors for this endothelial dysfunction include diabetes, hypertension, high cholesterol, smoking, obesity, sedentary lifestyle, and chronic stress — all common in Malaysian men. Both ESWT and P-Shot target aspects of this vascular pathology, but through different mechanisms.

ESWT: How It Works

Low-intensity extracorporeal shockwave therapy (Li-ESWT) uses a handheld device to deliver acoustic pressure waves — similar to ultrasound but with different parameters — to the shaft and base of the penis over a 15-20 minute session.

The biological effects are well-characterised:

• Angiogenesis: Shockwaves trigger release of VEGF (vascular endothelial growth factor), stimulating formation of new blood vessels in penile tissue. This directly increases the vascular supply available for erection.
• Endothelial activation: Mechanical stimulation activates endothelial cells to produce more nitric oxide synthase (eNOS), restoring NO production and smooth muscle relaxation capacity.
• Stem cell recruitment: Shockwaves attract progenitor cells that contribute to vascular and tissue repair.
• Plaque disruption: In men with Peyronie’s disease (fibrous plaques in the penis), shockwaves help break down these plaques, improving curvature and pain.

A meta-analysis of 14 randomised controlled trials showed significant improvement in IIEF (International Index of Erectile Function) scores with Li-ESWT, particularly in men with vasculogenic (vascular-cause) ED. Improvement persists for 12-24 months after treatment completion.

P-Shot: How It Works

The Priapus Shot (P-Shot) is a PRP (Platelet-Rich Plasma) injection for ED. The process:

1. Blood is drawn from the patient (typically 30-60ml).
2. Centrifugation concentrates platelets 4-8x above normal blood concentration.
3. The resulting PRP is injected into the penile shaft and glans using a fine needle after topical anaesthesia.

Platelets contain growth factors that drive multiple repair processes:

• PDGF: Stimulates smooth muscle cell proliferation and vascular repair.
• VEGF: Promotes angiogenesis — same target as ESWT but via a different mechanism.
• EGF: Supports tissue regeneration and nerve repair.
• TGF-beta: Modulates collagen production in penile tissue.

The P-Shot may be particularly effective for nerve-related ED (post-prostatectomy, diabetic neuropathy), sensitivity improvement, and Peyronie’s disease management.

Direct Comparison: ESWT vs P-Shot

Who Should Choose ESWT?

• Men with primary vasculogenic ED (diabetes, hypertension, high cholesterol, smokers, obese)
• Men who want to reduce or eliminate dependence on oral PDE5 inhibitors (Viagra, Cialis)
• Men with Peyronie’s disease (curved/painful erection)
• Men who prefer a completely non-invasive approach (no needles)
• Younger men (<45) with early vasculogenic ED seeking long-term structural vascular improvement

Who Should Consider the P-Shot?

• Men with post-prostatectomy ED (nerve damage is the primary factor)
• Men with diabetic neuropathy affecting penile sensation
• Men concerned about penile sensitivity loss
• Men with Peyronie’s disease alongside structural changes
• Men who want to complement ESWT with growth factor support

Lifestyle Factors That Determine Both Treatments’ Success

Neither ESWT nor P-Shot produces lasting results in isolation from lifestyle factors. The same risks that cause ED — vascular damage from metabolic disease, physical inactivity, smoking — continue to work against treated tissue if not addressed:

• Regular aerobic exercise: The most powerful natural eNOS activator. Running, cycling, or swimming 3-4x per week measurably improves endothelial function and amplifies ESWT results.
• Diabetes and blood pressure control: Uncontrolled diabetes and hypertension continue to damage endothelium even after successful treatment. Metabolic control is not optional.
• Testosterone optimisation: Low testosterone reduces eNOS expression, impairing NO production. Testosterone assessment alongside ESWT or P-Shot addresses all components of the hormonal-vascular ED picture.
• Smoking cessation: Nicotine directly impairs endothelial function. No amount of treatment overcomes the continuous endothelial damage from active smoking.

Frequently Asked Questions